Search Results - "Wong, Stuart J"

De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies by Mehanna, Hisham, Rischin, Danny, Wong, Stuart J, Gregoire, Vincent, Ferris, Robert, Waldron, John, Le, Quynh-Thu, Forster, Martin, Gillison, Maura, Laskar, Sarbani, Tahara, Makoto, Psyrri, Amanda, Vermorken, Jan, Porceddu, Sandro

“…Human papillomavirus (HPV)-positive oropharyngeal cancer (OPC) is increasing rapidly. The younger age, significantly improved prognosis, and relative morbidity…”
Get full text

Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Oncology Group Study RTOG 0214 by GORE, Elizabeth M, BAE, Kyounghwa, WONG, Stuart J, SUN, Alexander, BONNER, James A, SCHILD, Steven E, GASPAR, Laurie E, BOGART, Jeffery A, WERNER-WASIK, Maria, CHOY, Hak

“…This study was conducted to determine if prophylactic cranial irradiation (PCI) improves survival in locally advanced non-small-cell lung cancer (LA-NSCLC)…”
Get full text

Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Neurocognitive and Quality-of-Life Analysis by SUN, Alexander, BAE, Kyounghwa, WERNER- WASIK, Maria, CHOY, Hak, GORE, Elizabeth M, MOVSAS, Benjamin, WONG, Stuart J, MEYERS, Christina A, BONNER, James A, SCHILD, Steven E, GASPAR, Laurie E, BOGART, Jeffery A

“…There are scant data regarding the effects of prophylactic cranial irradiation (PCI) on neurocognitive function (NCF) and quality of life (QOL). Radiation…”
Get full text

Validation of NRG oncology/RTOG‐0129 risk groups for HPV‐positive and HPV‐negative oropharyngeal squamous cell cancer: Implications for risk‐based therapeutic intensity trials by Fakhry, Carole, Zhang, Qiang, Gillison, Maura L., Nguyen‐Tân, Phuc Felix, Rosenthal, David I., Weber, Randal S., Lambert, Louise, Trotti, Andy M., Barrett, William L., Thorstad, Wade L., Yom, Sue S., Wong, Stuart J., Ridge, John A., Rao, Shyam S. D., Spencer, Sharon, Fortin, Andre, Raben, David, Harris, Jonathan, Le, Quynh‐Thu

“…Background Radiation Therapy Oncology Group (RTOG)‐0129 recursive partitioning analysis was the basis for risk‐based therapeutic intensification trials for…”
Get full text

Reirradiation for Head and Neck Cancer: The Who and the How by Margalit, Danielle N., Wong, Stuart J.

Get full text

Locally Recurrent, Previously Irradiated Head and Neck Cancer: Concurrent Re-Irradiation and Chemotherapy, or Chemotherapy Alone? by WONG, Stuart J, MACHTAY, Mitchell, YI LI

“…Patients with locally recurrent head and neck cancer previously treated with radiation have a poor prognosis. Administration of a second course of radiation to…”
Get full text

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study by Cohen, Ezra EW, Dr, Davis, Darren W, PhD, Karrison, Theodore G, PhD, Seiwert, Tanguy Y, MD, Wong, Stuart J, MD, Nattam, Sreenivasa, MD, Kozloff, Mark F, MD, Clark, Joseph I, MD, Yan, Duen-Hwa, PhD, Liu, Wen, MD, Pierce, Carolyn, BA, Dancey, Janet E, MD, Stenson, Kerstin, MD, Blair, Elizabeth, MD, Dekker, Allison, BSN, Vokes, Everett E, Prof

“…Summary Background Epidermal growth factor receptor (EGFR) is a validated target in squamous-cell carcinoma of the head and neck, but in patients with…”
Get full text

A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck by DE SOUZA, Jonas A, DAVIS, Darren W, KUNNAVAKKAM, Rangesh, STENSON, Kerstin M, BLAIR, Elizabeth A, BOZEMAN, Jeffrey, DANCEY, Janet E, VOKES, Everett E, COHEN, Ezra E. W, YUJIAN ZHANG, KHATTRI, Arun, SEIWERT, Tanguy Y, AKTOLGA, Serdal, WONG, Stuart J, KOZLOFF, Mark F, NATTAM, Sreenivasa, LINGEN, Mark W

“…This study sought to determine the efficacy and safety profile of lapatinib in patients with recurrent/metastatic squamous cell carcinoma of the head and neck…”
Get full text

The Not Knowing Is the Hardest Part by Shukla, Monica E., MD, Wong, Stuart J., MD

Get full text

Radiation Therapy Oncology Group 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin With Concurrent Radiotherapy for Patients With Locally Advanced Rectal Cancer by Wong, Stuart J., M.D, Winter, Kathryn, M.S, Meropol, Neal J., M.D, Anne, Pramila Rani, M.D, Kachnic, Lisa, M.D, Rashid, Asif, M.D, Watson, James C., M.D, Mitchell, Edith, M.D, Pollock, Jondavid, M.D, Lee, Robert Jeffrey, M.D, Haddock, Michael, M.D, Erickson, Beth A., M.D, Willett, Christopher G., M.D

“…Purpose To evaluate the rate of pathologic complete response (pCR) and the toxicity of two neoadjuvant chemoradiotherapy (chemoRT) regimens for Stage T3-T4…”
Get full text

Efficacy Endpoints of Radiation Therapy Group Protocol 0247: A Randomized, Phase 2 Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer by Wong, Stuart J., MD, Moughan, Jennifer, MS, Meropol, Neal J., MD, Anne, Pramila Rani, MD, Kachnic, Lisa A., MD, Rashid, Asif, MBBS, PhD, Watson, James C., MD, Mitchell, Edith P., MD, Pollock, Jondavid, MD, Lee, R. Jeffrey, MD, Haddock, Michael, MD, Erickson, Beth A., MD, Willett, Christopher G., MD

“…Purpose To report secondary efficacy endpoints of Radiation Therapy Oncology Group protocol 0247, primary endpoint analysis of which demonstrated that…”
Get full text

Comparison of Physical Examination and Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography 4–6 Months After Radiotherapy to Assess Residual Head-and-Neck Cancer by Zundel, M. Tracy, M.D, Michel, Michelle A., M.D, Schultz, Christopher J., M.D, Maheshwari, Mohit, M.D, Wong, Stuart J., M.D, Campbell, Bruce H., M.D, Massey, Becky L., M.D, Blumin, Joel, M.D, Wilson, J. Frank, M.D, Wang, Dian, M.D., Ph.D

“…Purpose To retrospectively compare fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and physical examination 4–6 months after…”
Get full text

A phase 2 trial of a topical antiseptic bundle in head and neck cancer surgery: Effects on surgical site infection and the oral microbiome by Zenga, Joseph, Atkinson, Samantha, Yen, Tina, Massey, Becky, Stadler, Michael, Bruening, Jennifer, Peppard, William, Reuben, Michael, Hayward, Michael, Mesich, Brian, Buchan, Blake, Ledeboer, Nathan, Sanchez, Joyce L., Fraser, Raphael, Lin, Chien-Wei, Holtz, Mary L., Awan, Musaddiq, Wong, Stuart J., Puram, Sidharth V., Salzman, Nita

“…Head and neck cancer (HNC) surgery remains an important component of management but is associated with a high rate of surgical site infection (SSI). We aimed…”
Get full text

Clinical Outcomes of Patients Receiving Integrated PET/CT-Guided Radiotherapy for Head and Neck Carcinoma by Vernon, Matthew R., B.S, Maheshwari, Mohit, M.D, Schultz, Christopher J., M.D, Michel, Michelle A., M.D, Wong, Stuart J., M.D, Campbell, Bruce H., M.D, Massey, Becky L., M.D, Wilson, J. Frank, M.D, Wang, Dian, M.D., Ph.D

“…Purpose We previously reported the advantages of18 F-fluorodeoxyglucose–positron emission tomography (PET) fused with CT for radiotherapy planning over CT…”
Get full text

Good Radiosensitizer Hunting by Mell, Loren K, Wong, Stuart J

Get full text

Retreatment of Recurrent Head and Neck Cancer in a Previously Irradiated Field by Wong, Stuart J., MD, Bourhis, Jean, MD, Langer, Corey J., MD

“…During the past 2 decades, concurrent chemotherapy with reirradiation (reRT) has matured from a fear-provoking, rarely performed therapeutic strategy to an…”
Get full text

Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer by Fakhry, Carole, Zhang, Qiang, Nguyen-Tân, Phuc Felix, Rosenthal, David I, Weber, Randal S, Lambert, Louise, Trotti, 3rd, Andy M, Barrett, William L, Thorstad, Wade L, Jones, Christopher U, Yom, Sue S, Wong, Stuart J, Ridge, John A, Rao, Shyam S D, Bonner, James A, Vigneault, Eric, Raben, David, Kudrimoti, Mahesh R, Harris, Jonathan, Le, Quynh-Thu, Gillison, Maura L

“…Purpose Treatment of oropharyngeal squamous cell carcinoma (OPSCC) is evolving toward risk-based modification of therapeutic intensity, which requires…”
Get full text

Cancer trials as opportunities to serve and learn from individuals with human immunodeficiency virus by Henson, Christina E., Morton, Daniel J., Mayadev, Jyoti S., Wong, Stuart J., Zamarin, Dmitriy

“…Despite strong recommendations for their inclusion in cancer clinical trials, people living with human immunodeficiency virus continue to be underrepresented…”
Get full text

Pharmacokinetic Characterization and Bioavailability Barrier for the Key Active Components of Botanical Drug Antitumor B (ATB) in Mice for Chemoprevention of Oral Cancer by Bui, Dinh, Yin, Taijun, Duan, Shengnan, Wei, Bo, Yang, Peiying, Wong, Stuart J, You, Ming, Singh, Rashim, Hu, Ming

“…This study aims to characterize the pharmacokinetic (PK) profiles and identify important bioavailability barriers and pharmacological pathways of the key…”
Get full text

Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations by Wang, Kai, Russell, Jeffery S, McDermott, Jessica D, Elvin, Julia A, Khaira, Depinder, Johnson, Adrienne, Jennings, Timothy A, Ali, Siraj M, Murray, Molly, Marshall, Carrie, Oldham, Dwight S, Washburn, Donna, Wong, Stuart J, Chmielecki, Juliann, Yelensky, Roman, Lipson, Doron, Miller, Vincent A, Stephens, Philip J, Serracino, Hilary S, Ross, Jeffrey S, Bowles, Daniel W

“…We sought to identify genomic alterations (GA) in salivary gland adenocarcinomas, not otherwise specified (NOS), salivary duct carcinomas (SDC), carcinoma ex…”
Get full text